[1]
P. M. Wilson, “Implementation of inclisiran in UK primary care for patients with atherosclerotic cardiovascular disease (ASCVD) or ASCVD-risk equivalents: rationale and design of VICTORION-Spirit, a pragmatic phase IIIb, randomised controlled study”, Int J Clin Trials, vol. 10, no. 2, pp. 156–165, Apr. 2023.